BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33931143)

  • 1. Phyto-drug conjugated nanomaterials enhance apoptotic activity in cancer.
    Vimala K; Kannan S
    Adv Protein Chem Struct Biol; 2021; 125():275-305. PubMed ID: 33931143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytochemical based nanomedicines against cancer: current status and future prospects.
    Rizwanullah M; Amin S; Mir SR; Fakhri KU; Rizvi MMA
    J Drug Target; 2018 Nov; 26(9):731-752. PubMed ID: 29157022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytofabrication of Nanoparticles as Novel Drugs for Anticancer Applications.
    Wei QY; He KM; Chen JL; Xu YM; Lau ATY
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of nano-phytochemicals in cervical cancer therapy.
    Yadav N; Parveen S; Banerjee M
    Clin Chim Acta; 2020 Jun; 505():60-72. PubMed ID: 32017926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology for the delivery of phytochemicals in cancer therapy.
    Xie J; Yang Z; Zhou C; Zhu J; Lee RJ; Teng L
    Biotechnol Adv; 2016; 34(4):343-353. PubMed ID: 27071534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use.
    Dhupal M; Chowdhury D
    Int J Nanomedicine; 2020; 15():9125-9157. PubMed ID: 33244231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals.
    Li C; Zhang J; Zu YJ; Nie SF; Cao J; Wang Q; Nie SP; Deng ZY; Xie MY; Wang S
    Chin J Nat Med; 2015 Sep; 13(9):641-52. PubMed ID: 26412423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations.
    Upaganlawar A; Polshettiwar S; Raut S; Tagalpallewar A; Pande V
    Curr Drug Metab; 2022; 23(11):869-881. PubMed ID: 36065928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers.
    Kumar G; Virmani T; Sharma A; Pathak K
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the Anticancer Value of the Ursolic Acid Through Nanodelivery.
    Manayi A; Nikan M; Nobakht-Haghighi N; Abdollahi M
    Curr Med Chem; 2018; 25(37):4866-4875. PubMed ID: 28707589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breaking the Barrier of Cancer Through Liposome Loaded with Phytochemicals.
    Giri TK
    Curr Drug Deliv; 2019; 16(1):3-17. PubMed ID: 30227818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Nanotechnology with Nano-Phytochemicals: Molecular Mechanisms and Clinical Implications in Cancer Progression.
    Kim B; Park JE; Im E; Cho Y; Lee J; Lee HJ; Sim DY; Park WY; Shim BS; Kim SH
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin Loaded Nanoparticles in Targeting Cancer: Recent Development.
    Vinayak M; Maurya AK
    Anticancer Agents Med Chem; 2019; 19(13):1560-1576. PubMed ID: 31284873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytochemicals in Anticancer Drug Development.
    Dutt R; Garg V; Khatri N; Madan AK
    Anticancer Agents Med Chem; 2019; 19(2):172-183. PubMed ID: 30398123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
    Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
    Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug delivery to the eye: what benefits do nanocarriers offer?
    Joseph RR; Venkatraman SS
    Nanomedicine (Lond); 2017 Mar; 12(6):683-702. PubMed ID: 28186436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Cancer Via Resveratrol-Loaded Nanoparticles Administration: Focusing on In Vivo Evidence.
    Santos AC; Pereira I; Magalhães M; Pereira-Silva M; Caldas M; Ferreira L; Figueiras A; Ribeiro AJ; Veiga F
    AAPS J; 2019 Apr; 21(4):57. PubMed ID: 31016543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic Role of Dietary Phytochemicals in Cancer: Emerging Perspectives for Combinational Therapy.
    Banudevi S; Swaminathan S; Maheswari KU
    Nutr Cancer; 2015; 67(7):1021-48. PubMed ID: 26359767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.